Ping Lan

Latest

A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study
Senescence-based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies
Senescence-Based Colorectal Cancer Subtyping Reveals Distinct Molecular Characteristics and Therapeutic Strategies
Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis
Genome-Wide analysis reveals hypoxic microenvironment is associated with immunosuppression in poor survival of stage II/III colorectal cancer patients
Multi-omics longitudinal analyses in stages I to III CRC patients: Surveillance liquid biopsy test to predict early recurrence and enable risk-stratified postoperative CRC management.
Su029 INTEGRATING PROGNOSIS-RELATED GENES WITH IMMUNE-RELATED GENE SIGNATURE FOR SURVIVAL STRATIFICATION OF EARLY-STAGE COLORECTAL CANCER
A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer
Protein-protein interaction analysis reveals a novel cancer stem cell related target TMEM17 in colorectal cancer
Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients
Multiomics-based colorectal cancer molecular subtyping using local scaling network fusion
Hippo-YAP signaling controls lineage differentiation of mouse embryonic stem cells through modulating the formation of super-enhancers
Development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer
Multiomics-Based Colorectal Cancer Molecular Subtyping Using Local Scaling Network Fusion
A signature of hypoxia-related factors reveals functional dysregulation and robustly predicts clinical outcomes in stage I/II colorectal cancer patients
Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients